A study published in ACS Nano describes a vaccine platform that uses cell-derived extracellular vesicles (EVs) displaying inverted hemagglutinins (HAs) on their surface. The goal is a mucosal vaccine that protects the respiratory tract and helps prevent virus spread during epidemics or pandemics.
With the inverted arrangement the HA stalk becomes more exposed to the immune system while the variable HA head is less visible. The stalk contains conserved structures shared by many influenza strains, so targeting it can produce broader protection than strain-specific vaccines.
In mice, multiple HA-EV vaccines given intranasally elicited cross-reactive antibodies to HA stalks, robust virus-specific cellular immune responses and a balanced Th1/Th2 profile. Intranasal immunization with these vaccines provided complete protection against lethal heterosubtypic challenges with H7N9 and H5N1 reassortants. The authors note that EVs are a biocompatible delivery platform and that more mucosal vaccine strategies are needed.
Difficult words
- extracellular vesicle — a small membrane particle released by cellsextracellular vesicles
- hemagglutinin — a viral surface protein on influenza viruseshemagglutinins
- invert — to put something in the opposite positioninverted
- stalk — a supporting or connecting part of a proteinstalks
- cross-reactive — able to react with different but related targets
- mucosal — relating to the moist lining of body passages
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you prefer a mucosal vaccine given through the nose rather than an injection? Why or why not?
- What are the possible advantages of targeting the HA stalk instead of the HA head in influenza vaccines?
- What practical challenges might scientists face when developing more mucosal vaccine strategies?
Related articles
Clock disruption speeds breast cancer in models
New research finds that repeating disruption of the body’s 24-hour clock changes breast tissue, weakens immune defenses and leads to faster, more aggressive breast cancer in experimental models. The study links altered light–dark schedules to worse outcomes.
New oral Listeria vaccine shows promise against colorectal cancer
Researchers report a modified oral vaccine made from Listeria that primes immune cells in the gut and limits tumor growth in mice. The vaccine worked best when combined with immune checkpoint inhibitors and caused few side effects.
Cholera spreads where water and health systems fail
Cholera spread widely in 2024, with 560,823 reported cases and 6,028 deaths. Conflict, climate shocks and damaged water and health services drove outbreaks, while vaccines and better water and sanitation are key to preventing deaths.
Targeting inflammation as a way to treat depression
A federally funded review and meta-analysis found that anti-inflammatory treatments reduced depressive symptoms and eased anhedonia in people with depression who had high inflammation. The drugs were not FDA-approved for depression and would be used off-label.